Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05099380 · ClinicalTrials.gov registry record · NA
Validation of Senofilcon A With New UV / HEV Filter
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 296
- Enrollment target
NCT05099380 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 296 participants.
The verdict
NCT05099380, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 296 participants
- Enrollment target
Study Summary
This is a bilateral, dispensing, randomized, controlled, subject-masked, 2-arm parallel study to evaluate safety and efficacy
Interventions
- DEVICE senofilcon A
- DEVICE senofilcon A C3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 296 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2021-11-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05099380
The ClinicalTrials.gov registry entry for NCT05099380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.
NCT05099380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05099380 about?
NCT05099380 is a clinical study titled "Validation of Senofilcon A With New UV / HEV Filter". This is a bilateral, dispensing, randomized, controlled, subject-masked, 2-arm parallel study to evaluate safety and efficacy
What is the current status of trial NCT05099380?
This trial is currently completed. It is a NA study. The enrollment target is 296 participants. The study started on 2021-10-05. Estimated completion is 2021-11-24.
What interventions are being tested in trial NCT05099380?
The interventions under investigation include: senofilcon A (DEVICE), senofilcon A C3 (DEVICE).
Who is sponsoring clinical trial NCT05099380?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.